loadpatents
name:-0.098154783248901
name:-0.026817798614502
name:-0.0081288814544678
Trieselmann; Thomas Patent Filings

Trieselmann; Thomas

Patent Applications and Registrations

Patent applications and USPTO patent grants for Trieselmann; Thomas.The latest application filed is for "ccr2 receptor antagonists and uses thereof".

Company Profile
6.22.35
  • Trieselmann; Thomas - Mettenberg DE
  • Trieselmann; Thomas - Warthausen DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Heterocyclyl-substituted oxadiazolopyridine derivatives for use as ghrelin O-acyl transferase (GOAT) inhibitors
Grant 11,319,310 - Trieselmann , et al. May 3, 2
2022-05-03
Benzyl-, (pyridin-3-yl)methyl -or (pyridin-4-yl)-methyl-substituted oxadiazolopyridine derivatives as ghrelin O-acyl transferase (GOAT) inhibitors
Grant 11,254,688 - Trieselmann , et al. February 22, 2
2022-02-22
Ccr2 Receptor Antagonists And Uses Thereof
App 20220002310 - Ebel; Heiner ;   et al.
2022-01-06
Pyrazole- and indazole-substituted oxadiazolopyridine derivatives for use as ghrelin O-acyl transferase (GOAT) inhibitors
Grant 11,136,337 - Trieselmann , et al. October 5, 2
2021-10-05
CCR2 receptor antagonists and uses thereof
Grant 11,046,706 - Ebel , et al. June 29, 2
2021-06-29
Benzyl-, (pyridin-3-yl)methyl -or (pyridin-4-yl)-methyl-substiituted Oxadiazolopyridine Derivatives As Ghrelin O-acyl Transferase (goat) Inhibitors
App 20210053985 - TRIESELMANN; Thomas ;   et al.
2021-02-25
Pyrazole- And Indazole- Substituted Oxadiazolopyridine Derivatives For Use As Ghrelin O-acyl Transferase (goat) Inhibitors
App 20210040113 - TRIESELMANN; Thomas ;   et al.
2021-02-11
Heterocyclyl-substituted Oxadiazolopyridine Derivatives For Use As Ghrelin O-acyl Transferase (goat) Inhibitors
App 20210040077 - TRIESELMANN; Thomas ;   et al.
2021-02-11
Triazolopyrimidine Derivatives For Use As Ghrelin O-acyl Transferase (goat) Inhibitors
App 20210038603 - TRIESELMANN; Thomas ;   et al.
2021-02-11
Ccr2 Receptor Antagonists And Uses Thereof
App 20190300541 - Ebel; Heiner ;   et al.
2019-10-03
Oxadiazolopyridine derivatives for use as ghrelin O-acyl transferase (GOAT) inhibitors
Grant 10,308,667 - Godbout , et al.
2019-06-04
CCR2 receptor antagonists and uses thereof
Grant 10,196,402 - Ebel , et al. Fe
2019-02-05
Oxadiazolopyridine Derivatives for Use as Ghrelin O-Acyl Transferase (GOAT) Inhibitors
App 20180251476 - GODBOUT; Cedrickx ;   et al.
2018-09-06
Oxadiazolopyridine derivates for use as ghrelin O-acyl transferase (GOAT) inhibitors
Grant 9,994,591 - Godbout , et al. June 12, 2
2018-06-12
Oxadiazolopyridine Derivates for Use as Ghrelin O-Acyl Transferase (GOAT) Inhibitors
App 20180037594 - GODBOUT; Cedrickx ;   et al.
2018-02-08
New Ccr2 Receptor Antagonists And Uses Thereof
App 20170362249 - Ebel; Heiner ;   et al.
2017-12-21
CCR2 receptor antagonists and uses thereof
Grant 9,670,222 - Ebel , et al. June 6, 2
2017-06-06
Furo[3,4-c]quinoline derivatives, medicaments containing such compounds, their use and process for their preparation
Grant 9,150,583 - Trieselmann , et al. October 6, 2
2015-10-06
Process and intermediates for the production of CCR2 antagonists
Grant 9,067,951 - Ebel , et al. June 30, 2
2015-06-30
Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation
Grant 9,029,544 - Wagner , et al. May 12, 2
2015-05-12
Process And Intermediates For The Production Of Ccr2 Antagonists
App 20140336374 - EBEL; Heiner ;   et al.
2014-11-13
Cyclic pyrimidin-4-carboxamides as CCR2 receptor antagonists for treatment of inflammation, asthma and COPD
Grant 8,835,440 - Ebel , et al. September 16, 2
2014-09-16
CCR2 receptor antagonists and uses thereof
Grant 8,765,949 - Ebel , et al. July 1, 2
2014-07-01
Cyclic Pyrimidin-4-carboxamides As Ccr2 Receptor Antagonists For Treatment Of Inflammation, Asthma And Copd
App 20130324517 - EBEL; Heiner ;   et al.
2013-12-05
Furo[3,4-c]quinoline derivatives, medicaments containing such compounds, their use and process for their preparation
App 20130210850 - TRIESELMANN; Thomas ;   et al.
2013-08-15
Novel Antagonists For Ccr2 And Uses Thereof
App 20130143905 - Ebel; Heiner ;   et al.
2013-06-06
Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation
App 20130053404 - Wagner; Holger ;   et al.
2013-02-28
Cyclic Pyrimidin-4-carboxamides As Ccr2 Receptor Antagonists For Treatment Of Inflammation, Asthma And Copd
App 20120053164 - Ebel; Heiner ;   et al.
2012-03-01
Tricyclic Pyridine Derivatives, Medicaments Containing Such Compounds, Their Use And Process For Their Preparation
App 20120053197 - WAGNER; Holger ;   et al.
2012-03-01
Tricyclic Pyridine Derivatives, Medicaments Containing Such Compounds, Their Use And Process For Their Preparation
App 20120046304 - WAGNER; Holger ;   et al.
2012-02-23
New Ccr2 Receptor Antagonists And Uses Thereof
App 20120004252 - Ebel; Heiner ;   et al.
2012-01-05
Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions
Grant 7,977,334 - Trieselmann , et al. July 12, 2
2011-07-12
Indol-containing beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions
Grant 7,754,756 - Walter , et al. July 13, 2
2010-07-13
Use of aminoalcohol derivatives for the treatment of overactive bladder
App 20090221589 - Trieselmann; Thomas ;   et al.
2009-09-03
Novel Beta-Agonists, Process for Their Preparation and Their Use as Medicaments
App 20080300290 - Walter; Rainer ;   et al.
2008-12-04
Novel Beta-Agonists, Method for Producing Them and Their Use as Drugs
App 20080269281 - Trieselmann; Thomas ;   et al.
2008-10-30
Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions
App 20080234278 - Trieselmann; Thomas ;   et al.
2008-09-25
Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions
App 20080103138 - Trieselmann; Thomas ;   et al.
2008-05-01
Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions
App 20070112033 - Trieselmann; Thomas ;   et al.
2007-05-17
Indol-containing beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions
App 20070105906 - Walter; Rainer ;   et al.
2007-05-10
Beta-agonists, processes for preparing them and their use as pharmaceutical compositions
Grant 7,214,698 - Trieselmann , et al. May 8, 2
2007-05-08
Use of substituted 2-phenylbenzimidazoles as medicaments
Grant 7,151,114 - Streicher , et al. December 19, 2
2006-12-19
New beta-agonists, processes for preparing them and their use as pharmaceutical compositions
App 20060173061 - Trieselmann; Thomas ;   et al.
2006-08-03
Cyanothiophenes, their preparation and their use in pharmaceutical compositions
App 20060094764 - Anderskewitz; Ralf ;   et al.
2006-05-04
Beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions
App 20050245526 - Trieselmann, Thomas ;   et al.
2005-11-03
Use of substituted 2 phenylbenzimidazoles as medicaments
App 20050014810 - Streicher, Ruediger ;   et al.
2005-01-20
New beta-agonists, processes for preparing them and their use as pharmaceutical compositions
App 20040127733 - Trieselmann, Thomas ;   et al.
2004-07-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed